Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring

Chang Liu, Zhen Zhao, Jia Fan, Christopher J. Lyon, Hung Jen Wu, Dobrin Nedelkov, Adrian M. Zelazny, Kenneth N. Olivier, Lisa H. Cazares, Steven M. Holland, Edward A. Graviss, Ye Hu

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Tuberculosis (TB) is a major global health threat, resulting in an urgent unmet need for a rapid, non–sputum-based quantitative test to detect active Mycobacterium tuberculosis (Mtb) infections in clinically diverse populations and quickly assess Mtb treatment responses for emerging drug-resistant strains. We have identified Mtb-specific peptide fragments and developed a method to rapidly quantify their serum concentrations, using antibody-labeled and energy-focusing porous discoidal silicon nanoparticles (nanodisks) and high-throughput mass spectrometry (MS) to enhance sensitivity and specificity. NanoDisk-MS diagnosed active Mtb cases with high sensitivity and specificity in a case-control study with cohorts reflecting the complexity of clinical practice. Similar robust sensitivities were obtained for cases of culture-positive pulmonary TB (PTB; 91.3%) and extrapulmonary TB (EPTB; 92.3%), and the sensitivities obtained for culture-negative PTB (82.4%) and EPTB (75.0%) in HIV-positive patients significantly outperformed those reported for other available assays. NanoDisk-MS also exhibited high specificity (87.1–100%) in both healthy and high-risk groups. Absolute quantification of serum Mtb antigen concentration was informative in assessing responses to antimycobacterial treatment. Thus, a NanoDisk-MS assay approach could significantly improve the diagnosis and management of active TB cases, and perhaps other infectious diseases as well.

Original languageEnglish (US)
Pages (from-to)3969-3974
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume114
Issue number15
DOIs
StatePublished - Apr 11 2017

Fingerprint

Mycobacterium tuberculosis
Mass Spectrometry
Peptides
Tuberculosis
Sensitivity and Specificity
Mycobacterium Infections
Peptide Fragments
Silicon
Therapeutics
Serum
Pulmonary Tuberculosis
Nanoparticles
Communicable Diseases
Case-Control Studies
HIV
Mycobacterium tuberculosis antigens
Antibodies
Pharmaceutical Preparations
Population

Keywords

  • Blood test
  • Nanodisk
  • Rapid diagnosis
  • Treatment monitoring
  • Tuberculosis

ASJC Scopus subject areas

  • General

Cite this

Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring. / Liu, Chang; Zhao, Zhen; Fan, Jia; Lyon, Christopher J.; Wu, Hung Jen; Nedelkov, Dobrin; Zelazny, Adrian M.; Olivier, Kenneth N.; Cazares, Lisa H.; Holland, Steven M.; Graviss, Edward A.; Hu, Ye.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, No. 15, 11.04.2017, p. 3969-3974.

Research output: Contribution to journalArticle

Liu, Chang ; Zhao, Zhen ; Fan, Jia ; Lyon, Christopher J. ; Wu, Hung Jen ; Nedelkov, Dobrin ; Zelazny, Adrian M. ; Olivier, Kenneth N. ; Cazares, Lisa H. ; Holland, Steven M. ; Graviss, Edward A. ; Hu, Ye. / Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring. In: Proceedings of the National Academy of Sciences of the United States of America. 2017 ; Vol. 114, No. 15. pp. 3969-3974.
@article{80307e1d674e45e28f1555a5490c4eeb,
title = "Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring",
abstract = "Tuberculosis (TB) is a major global health threat, resulting in an urgent unmet need for a rapid, non–sputum-based quantitative test to detect active Mycobacterium tuberculosis (Mtb) infections in clinically diverse populations and quickly assess Mtb treatment responses for emerging drug-resistant strains. We have identified Mtb-specific peptide fragments and developed a method to rapidly quantify their serum concentrations, using antibody-labeled and energy-focusing porous discoidal silicon nanoparticles (nanodisks) and high-throughput mass spectrometry (MS) to enhance sensitivity and specificity. NanoDisk-MS diagnosed active Mtb cases with high sensitivity and specificity in a case-control study with cohorts reflecting the complexity of clinical practice. Similar robust sensitivities were obtained for cases of culture-positive pulmonary TB (PTB; 91.3{\%}) and extrapulmonary TB (EPTB; 92.3{\%}), and the sensitivities obtained for culture-negative PTB (82.4{\%}) and EPTB (75.0{\%}) in HIV-positive patients significantly outperformed those reported for other available assays. NanoDisk-MS also exhibited high specificity (87.1–100{\%}) in both healthy and high-risk groups. Absolute quantification of serum Mtb antigen concentration was informative in assessing responses to antimycobacterial treatment. Thus, a NanoDisk-MS assay approach could significantly improve the diagnosis and management of active TB cases, and perhaps other infectious diseases as well.",
keywords = "Blood test, Nanodisk, Rapid diagnosis, Treatment monitoring, Tuberculosis",
author = "Chang Liu and Zhen Zhao and Jia Fan and Lyon, {Christopher J.} and Wu, {Hung Jen} and Dobrin Nedelkov and Zelazny, {Adrian M.} and Olivier, {Kenneth N.} and Cazares, {Lisa H.} and Holland, {Steven M.} and Graviss, {Edward A.} and Ye Hu",
year = "2017",
month = "4",
day = "11",
doi = "10.1073/pnas.1621360114",
language = "English (US)",
volume = "114",
pages = "3969--3974",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "15",

}

TY - JOUR

T1 - Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring

AU - Liu, Chang

AU - Zhao, Zhen

AU - Fan, Jia

AU - Lyon, Christopher J.

AU - Wu, Hung Jen

AU - Nedelkov, Dobrin

AU - Zelazny, Adrian M.

AU - Olivier, Kenneth N.

AU - Cazares, Lisa H.

AU - Holland, Steven M.

AU - Graviss, Edward A.

AU - Hu, Ye

PY - 2017/4/11

Y1 - 2017/4/11

N2 - Tuberculosis (TB) is a major global health threat, resulting in an urgent unmet need for a rapid, non–sputum-based quantitative test to detect active Mycobacterium tuberculosis (Mtb) infections in clinically diverse populations and quickly assess Mtb treatment responses for emerging drug-resistant strains. We have identified Mtb-specific peptide fragments and developed a method to rapidly quantify their serum concentrations, using antibody-labeled and energy-focusing porous discoidal silicon nanoparticles (nanodisks) and high-throughput mass spectrometry (MS) to enhance sensitivity and specificity. NanoDisk-MS diagnosed active Mtb cases with high sensitivity and specificity in a case-control study with cohorts reflecting the complexity of clinical practice. Similar robust sensitivities were obtained for cases of culture-positive pulmonary TB (PTB; 91.3%) and extrapulmonary TB (EPTB; 92.3%), and the sensitivities obtained for culture-negative PTB (82.4%) and EPTB (75.0%) in HIV-positive patients significantly outperformed those reported for other available assays. NanoDisk-MS also exhibited high specificity (87.1–100%) in both healthy and high-risk groups. Absolute quantification of serum Mtb antigen concentration was informative in assessing responses to antimycobacterial treatment. Thus, a NanoDisk-MS assay approach could significantly improve the diagnosis and management of active TB cases, and perhaps other infectious diseases as well.

AB - Tuberculosis (TB) is a major global health threat, resulting in an urgent unmet need for a rapid, non–sputum-based quantitative test to detect active Mycobacterium tuberculosis (Mtb) infections in clinically diverse populations and quickly assess Mtb treatment responses for emerging drug-resistant strains. We have identified Mtb-specific peptide fragments and developed a method to rapidly quantify their serum concentrations, using antibody-labeled and energy-focusing porous discoidal silicon nanoparticles (nanodisks) and high-throughput mass spectrometry (MS) to enhance sensitivity and specificity. NanoDisk-MS diagnosed active Mtb cases with high sensitivity and specificity in a case-control study with cohorts reflecting the complexity of clinical practice. Similar robust sensitivities were obtained for cases of culture-positive pulmonary TB (PTB; 91.3%) and extrapulmonary TB (EPTB; 92.3%), and the sensitivities obtained for culture-negative PTB (82.4%) and EPTB (75.0%) in HIV-positive patients significantly outperformed those reported for other available assays. NanoDisk-MS also exhibited high specificity (87.1–100%) in both healthy and high-risk groups. Absolute quantification of serum Mtb antigen concentration was informative in assessing responses to antimycobacterial treatment. Thus, a NanoDisk-MS assay approach could significantly improve the diagnosis and management of active TB cases, and perhaps other infectious diseases as well.

KW - Blood test

KW - Nanodisk

KW - Rapid diagnosis

KW - Treatment monitoring

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85020227169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020227169&partnerID=8YFLogxK

U2 - 10.1073/pnas.1621360114

DO - 10.1073/pnas.1621360114

M3 - Article

VL - 114

SP - 3969

EP - 3974

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 15

ER -